NMDA receptor activity and the transmission of sensory input into motor output in introverts and extraverts

Quarterly Journal of Experimental Psychology Section B: Comparative and Physiological Psychology

Volumn 56 B, Issue 2, 2003, Pages 207-221

  Rammsayer, Thomas H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXTRAVERSION; FEMALE; HUMAN; MALE; MOTOR CORTEX; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME;

ADULT; DOPAMINE AGENTS; DOUBLE-BLIND METHOD; EXTRAVERSION (PSYCHOLOGY); FEMALE; HUMANS; MALE; MEMANTINE; MOTOR CORTEX; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0242297829     PISSN: 02724995     EISSN: None     Source Type: Journal    
DOI: 10.1080/02724990244000098     Document Type: Article

References (115)

1. Albin, R.L., Young, A.B., & Penney, J.B. (1989). The functional anatomy of basal ganglia disorders. Trends in Neurosciences, 12, 366-375.
2. Alexander, G.E., & Crutcher, M.D. (1990). Functional architecture of basal ganglia circuits: Neural substrates of parallel processing. Trends in Neurosciences, 13, 266-271.
3. Amalric, M., Berhow, M., Polis, I., & Koob, G.F. (1993). Selective effects of low-dose D2 dopamine receptor antagonism in a reaction-time task in rats. Neuropsychopharmacology, 8, 195-200.
4. Barratt, E. (1967). Perceptual-motor performance related to impulsiveness and anxiety. Perceptual Motor Skills, 25, 485-492.
5. Betarbet, R., & Greenamyre, T.J. (1999). Differential expression of glutamate receptors by the dopaminergic neurons of the primate striatum. Experimental Neurology, 159, 401-408.
6. Björklund, A., & Lindvall, O. (1986). Catecholaminergic brain stem regulatory systems. In American Physiological Society (Ed.), Handbook of physiology. Section 1. The nervous system. Vol. IV Intrinsic regulatory systems of the brain (pp. 155-235). Bethesda, MD: American Physiological Society.
7. Bormann, J. (1989). Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. European Journal of Pharmacology, 166, 591-592.
8. Brebner, J. (1985). Personality theory and movement. In B. Kirkcaldy (Ed.), Individual differences in movement (pp. 27-41). Lancaster, UK: MTP Press.
9. Breier, A., Adler, C.M., Weisenfeld, N., Su, T.P., Elman, I., Picken, L., Malhotra, A.K., & Pickar, D. (1998). Effects of WDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach. Synapse, 29, 142-147.
10. Brodie, H.K.H., Murphy, D.L., Goodwin, F.K., & Bunney, W.E. (1971). Catecholamines and mania: The effect of α-methyl-para-tyrosine on manic behavior and catecholamine metabolism. Clinical Pharmacology and Therapeutics, 12, 218-224.
11. Brozoski, T.J., Brown, R.M., Rosvold, H.E., & Goldman, P. (1979). Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science, 205, 929-931.
12. Bubser, M., Keseberg, U., Notz, P.K., & Schmidt, W.J. (1992). Differential behavioral and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. European Journal of Pharmacology, 229, 75-82.
13. Carlson, J., Bergstrom, D.A., Demo, S., & Walters, J.R. (1990). Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D1 and D2 dopamine agonists in rat globus pallidus. Synapse, 5, 83-93.
14. Carlsson, A., Roos, B.E., Wålinder, L., & Skott, A. (1973). Further studies on the mechanism of antipsychotic action: Potentiation by α-methyltyrosine of thioridazine effects in chronic schizophrenics. Journal of Neural Transmission, 34, 125-132.
15. Carlsson, A., Waters, N., Waters, S., & Carlsson, M.L. (2000). Network interactions in schizophrenia - therapeutic implications. Brain Research Reviews, 31, 342-349.
16. Carlsson, M.L., & Carlsson, A. (1989). The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. Journal of Neural Transmission, 75, 221-226.
17. Castro, S.L., & Zigmond, M.J. (2001). Stress-induced increase in extracellular dopamine in striatum: Role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra. Brain Research, 901, 47-54.
18. Chen, H.-S.V., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E., & Lipton, S.A. (1992). Open channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against N-receptor mediated neurotoxicity. Journal of Neuroscience, 12, 4427-4436.
19. Claridge, G.S., & Herrington, R.N. (1963). Excitation-inhibition and the theory of neurosis: A study of the sedatic threshold. In H.J. Eysenck (Ed.), Experiments with drugs (pp. 131-168). London: Pergamon.
20. Cohen, J.D., & Servan-Schreiber, D. (1992). Context, cortex, and dopamine: A connectionist approach to behavior and biology in schizophrenia. Psychological Review, 99, 45-77.
21. Corr, P.J., & Kumari, V. (1997). Sociability/impulsivity and attenuated dopaminergic arousal: Critical flicker/fusion frequency and procedural learning. Personality and Individual Differences, 22, 805-815.
22. Corr, P.J., Pickering, A.D., & Gray, J.A. (1995). Sociability impulsivity and caffeine-induced arousal effects: Critical flicker/fusion frequency and procedural learning. Personality and Individual Differences, 18, 713-730.
23. Creese, I. (1987). Biochemical properties of CNS dopamine receptors. In H.Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 257-264). New York: Raven Press.
24. Danysz, W., Parsons, C.G., Bresink, L., & Quack, G. (1995). Glutamate in CNS disorders a revived target for drug development? Drug News Perspective, 8, 261-277.
25. Davis, K.L., Kahn, R.S., Ko, G., & Davidson, M. (1991). Dopamine in schizophrenia: A review and reconceptualization. American Journal of Psychiatry, 148, 1474-1486.
26. De Keyser, J. (1993). Subtypes and localization of dopamine receptors in human brain. Neurochemistry International, 22, 83-93.
27. De Lecuona, J.M., Joseph, K.S., Iqbal, N., & Asnis, G.M. (1993). Dopamine hypothesis of schizophrenia revisited. Psychiatric Annals, 23, 179-185.
28. DeLong, M.R. (1990). Primate models of movement disorders of basal ganglia origin. Trends in Neurosciences, 13, 281-285.
29. Depue, R.A., & Collins, P.F. (1999). Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion. Behavioral and Brain Sciences, 22, 491-533.
30. Depue, R.A., Luciana, M., Arbisi, R., Collins, P., & Leon, A. (1994). Dopamine and the structure of personality: Relation of agonist-induced dopamine activity to positive emotionality. Journal of Personality and Social Psychology, 67, 485-498.
31. Deutsch, A.Y. (1992). The regulation of subcortical dopamine systems by the prefrontal cortex interaction of central dopamine systems and the pathogenesis of schizophrenia. Journal of Neural Transmission, Suppl. 36, 61-89.
32. Deutsch, A.Y., Tam, S.-Y., Freeman, A.S., Bowers, M.B.J., & Roth, R.H. (1987). Mesolimbic and mesocortical dopamine activation induced by phencyclidine: Contrasting pattern to striatal response. European Journal of Pharmacology, 134, 257-264.
33. Deutsch, S.L., Rosse, R.B., Schwartz, B.L., & Mastropaolo, J. (2001). A revised excitotoxic hypothesis of schizophrenia: Therapeutic implications. Clinical Neuropharmacology, 24, 43-49.
34. Dornic, S., & Ekehammar, B. (1990). Extraversion, neuroticism, and noise sensitivity. Personality and Individual Differences, 11, 989-992.
35. Doucet, C., & Stelmack, R.M. (1997). Movement time differentiates extraverts from introverts. Personality and Individual Differences, 23, 775-786.
36. Doucet, C., & Stelmack, R.M. (2000). An event-related potential analysis of extraversion and individual differences in cognitive processing speed and response execution. Journal of Personality and Social Psychology, 78, 956-964.
37. Duncan, G.E., Sheitman, B.B., & Lieberman, J.A. (1999). An integrated view of pathophysiological models of schizophrenia. Brain Research Reviews, 29, 250-264.
38. Dunnett, S.B., & Robbins, T.W. (1992). The functional role of the mesotelencephalic dopamine systems. Biological Reviev, 67, 491-518.
39. Eysenck, H.J. (1967). The biological basis of personality. Springfield, IL: Thomas.
40. Eysenck, H.J. (1994). Personality: Biological foundations. In P.A. Vernon (Ed.), The neuropsychology of individual differences (pp. 151-207). San Diego: Academic Press.
41. Eysenck, H.L., & Eysenck, S.B.G. (1991). Manual of the Eysenck Personality Scales (EPS Adult). London: Hodder and Stoughton.
42. Fallon, J.H., & Loughlin, S.E. (1987). Monoamine innervation of the cerebral cortex and a theory of the role of monoamines in cerebral cortex and basal ganglia. In E.G. Jones & A. Peters (Eds.), Cerebral cortex, Vol. 6: Further aspects of cortical function, including hippocampus (pp. 41-127). New York: Plenum.
43. Fischer, H., Wik, G., & Fredrikson, M. (1997). Extraversion, neuroticism and brain function: A PET study of personality. Personality and Individual Differences, 23, 345-352.
44. Fleischhacker, W.W., Buchgeher, A., & Schubert, H. (1986). Memantine in the treatment of senile dementia of the Alzheimer type. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10, 87-93.
45. Frewer, L.J., & Hindmarch, I. (1988). The effect of time of day, age, and anxiety on a choice reaction task. In I. Hindmarch, B. Aufdembrinke, & H. Ott (Eds.), Psychopharmacology and reaction time (pp. 103-114). Chichester, UK: John Wiley.
46. Geen, R.G. (1984). Preferred stimulation levels in introverts and extraverts: Effects on arousal and performance. Journal of Personality and Social Psychology, 46, 1303-1312.
47. Goff, D.C. (2000). Glutamate receptors in schizophrenia and antipsychotic drugs. In M.S. Lidow (Ed.), Neurotransmitter receptors in actions of antipsychotic medications (pp. 121-136). New York: CRC Press.
48. Goff, D.C., & Coyle, J.T. (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry, 158, 1367-1377.
49. Goldman-Rakic, P.S. (1992). Dopamine-mediated mechanisms of the prefrontal cortex. Seminars in the Neurosciences, 4, 149-159.
50. Goldman-Rakic, P.S. (1996). Regional and cellular fractionation of working memory. Proceedings of the National Academy of Sciences of the United States of America, 93, 13473-13480.
51. Grace, A.A. (1991). Phasic vs. tonic dopamine release and the modulation of dopamine system responsivity. A hypothesis for the etiology of schizophrenia. Neuroscience, 41, 1-24.
52. Graybiel, A.M., Aosaki, T., Flaherty, A.W., & Kimura, M. (1994). The basal ganglia and adaptive motor control. Science, 265, 1826-1831.
53. Haier, R.J., Reynolds, C., Prager, E., Cox, S., & Buchsbaum, M.S. (1991). Flurbiprofen, caffeine and analgesia: Interaction with introversion/extraversion. Personality and Individual Differences, 12, 1349-1354.
54. Halliday, R., Callaway, E., Naylor, H., Gratzinger, P., & Prael, R. (1986). The effect of stimulant drugs on information processing in elderly adults. Journal of Gerontology, 41, 748-757.
55. Hindmarch, I. (1982). Critical flicker fusion frequency (CFF): The effects of psychotropic compounds. Pharmacopsychiatry, 15 (Suppl. 1), 44-48.
56. Hondo, H., Yonezawa, Y., Nakahara, T., Nakamura, K., Hirano, H., Uchimaura, N., & Tashiro, N. (1994). Effect of phencyclidine on dopamine release in the rat prefrontal cortex, an in vivo microdialysis study. Brain Research, 633, 337-342.
57. Jackson, M.E., & Moghaddam, B. (2001). Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. Journal of Neuroscience, 21, 676-681.
58. Janke, W. (1983). Response variability to psychotropic drugs. Oxford: Pergamon Press.
59. Jentsch, J.D., & Roth, R.H. (1999). The neuropsychopharmacology of phencyclidine: From WDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 20, 201-225.
60. Jentsch, J.D., Taylor, J.R., & Roth, R.H. (1998). Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology, 19, 105-113.
61. Kimberg, D.Y., D'Esposito, M., & Farah, M.J. (1997). Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport, 8, 3581-3585.
62. Kirk, R.E. (1995). Experimental design: Procedures for the behavioral sciences. Pacific Grove, CA: Brooks/Cole Publishing Company.
63. Köhler, C., Hall, H., Magnusson, O., Lewander, T., & Gustafsson, K. (1990). Biochemical pharmacology of the atypical neuroleptic remoxipride. Acta Psychiatrica Scandinavica, 82 (Suppl.), 27-36.
64. Kohn, P.M. (1987). Issues in the measurement of arousability. In J. Strelau & H.J. Eysenck (Eds.), Personality dimensions and arousal (pp. 233-250). New York: Plenum Press.
65. Kornhuber, L., Weller, M., Schoppmeyer, K., & Riederer, P. (1994). Amantadine and memantine are NMDA receptor antagonists. Journal of Neural Transmission, 43, 91-104.
66. Kretschmer, B. (2000). NMDA receptor antagonist-induced dopamine release in the ventral pallidum does not correlate with motor activation. Brain Research, 859, 147-156.
67. Kretschmer, B.D., Goiny, M., & Herrera-Marschitz, M. (2000). Effect of intracerebral administration of WDA and AMPA on dopamine and glutamate release in the ventral pallidum and on motor behavior. Journal of Neurochemistry, 74, 2049-2057.
68. Krystal, J.H., D'Souza, D.C, Petrakis, I.L., Belger, A., Berman, R., Charney, D.S., Abi-Saab, W., & Madonick, S. (1999). NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies for neuropsychiatric disorders. Harvard Review of Psychiatry, 7, 125-133.
69. Lathi, A.C., Koffel, B., LaPorte, D., & Tamminga, C.A. (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology, 13, 9-19.
70. Laux, L., Glanzmann, P., Schaffner, P., & Spielberger, C.D. (1981). Das State-Trait-Angstinventar [The State-Trait Anxiety Inventory]. Weinheim, Germany: Beltz Testgesellschaft.
71. Le Moal, M., & Simon, H. (1991). Mesocorticolimbic dopaminergic network: Functional and regulatory roles. Physiological Reviews, 71, 155-234.
72. Lidow, M.S., Elsworth, J.D., & Goldman-Rakic, P.S. (1997). Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. Journal of Pharmacology and Experimental Therapeutics, 281, 597-603.
73. Lidow, M.S., & Goldman-Rakic, P.S. (1994). A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America, 91, 4353-4356.
74. Luciana, M., Depue, R.A., Arbisi, P., & Leon, A. (1992). Facilitation of working memory in humans by a D2 dopamine receptor agonist. Journal of Cognitive Neuroscience, 4, 58-68.
75. Malhotra, A.K., Pinals, D.A., Adler, C.M., Elman, T., Clifton, A., Pickar, D., & Breier, A. (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology, 17, 141-150.
76. Malhotra, A.K., Pinals, D.A., Weingartner, H., Sirocco, K., Missar, C.D., Pickar, D., & Breier, A. (1996). NMDA receptor function and human cognition - the effects of ketamine in healthy volunteers. Neuropsychopharmacology, 14, 301-1307.
77. Malmberg, A., Jackson, D.M., Eriksson, A., & Mohell, N. (1993). Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Molecular Pharmacology, 43, 749-754.
78. Mink, J.W. (1999). Basal ganglia. In M.J. Zigmond, F.E., Bloom, S.C. Landis, J.L. Roberts, & L.R. Squire (Eds.), Fundamental neuroscience (pp. 951-972). San Diego: Academic Press.
79. Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997). Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruption associated with the prefrontal cortex. Journal of Neuroscience, 17, 2921-2927.
80. Müller, U., von Cramon, D.Y., & Polimann, S. (1998). D1- versus D2-receptor modulation of visuospatial working memory in humans. Journal of Neuroscience, 18, 2720-2728.
81. Netter, P., & Hennig, J. (1999). Moderators and mechanisms relating personality to reward and dopamine: Some findings and open questions. Behavioral and Brain Sciences, 22, 531-532.
82. Pantev, M., Ritter, R., & Görtelmeyer, R. (1993). Clinical and behavioural evaluation in long-term care patients with mild to moderate dementia under memantine treatment. Zeitschriftfür Gerontopsychologie und-psychiatrie, 6, 103-117.
83. Pickering, A.D., & Gray, J.A. (2001). Dopamine, appetitive reinforcement, and the neuropsychology of human learning: An individual differences approach. In A. Eliasz & A. Angleitner (Eds.), Advances in research on temperament (pp. 113-149). Warsaw, Poland: Pabst.
84. Pollack, A.E. (2001). Anatomy, physiology, and pharmacology of the basal ganglia. Neurologic Clinics, 19, 523-534.
85. Rabey, J.M., Nissipeanu, P., & Korczyn, A.D. (1992). Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson' s disease. Journal of Neural Transmission, 4, 277-282.
86. Rammsayer, T. (1995). Extraversion and alcohol: Eysenck's drug postulate revisited. Neuropsychobiology, 32, 197-207.
87. Rammsayer, T. (1998). Extraversion and dopamine: Individual differences in responsiveness to changes in dopaminergic activity as a possible biological basis of extraversion. European Psychologist, 3, 37-50.
88. Rammsayer, T., Netter, P., & Vogel, W.H. (1993). A neurochemical model underlying differences in reaction times between introverts and extraverts. Personality and Individual Differences, 14, 701-712.
89. Reading, P.J., & Dunnett, S.B. (1991). The effects of excitotoxic lesions of the nucleus accumbens on a matching to position task. Behavioural Brain Research, 46, 17-29.
90. Robbins, T.W., & Everitt, B.J. (1987). Psychopharmacological studies of arousal and attention. In S.M. Stahl, S.D. Iversen, & E.C. Goodman (Eds.), Cognitive neurochemistry (pp. 135-170). Oxford: Oxford University Press.
91. Roth, R.H. (1979). Dopamine autoreceptors: Pharmacology, function and comparison with postsynaptic dopamine receptors. Communications in Psychopharmacology, 3, 429-445.
92. Ruch, W. (1999). Die revidierte Fassung des Eysenck Personality Questionnaire und die Konstruktion des deutschen EPQ-R bzw. EPQ-RK. [The Eysenck Personality Questionnaire-Revised and the construction of German standard and short versions, EPQ-R and EPQ-RK]. Zeitschrift für Differentielle und Diagnostische Psychologie, 20, 1-24.
93. Salamone, J.D., Kurth, P.A., McCullough, L.D., Sokolowski, J.D., & Cousins, M.S. (1993). The role of brain dopamine in response initiation: Effects of haloperidol and regionally-specific dopamine depletion on the local rate of instrumental responding. Brain Research, 628, 218-226.
94. Sawaguchi, T., Matsumura, M., & Kubota, K. (1990). Effects of dopamine antagonists on neuronal activity related to a delayed response task in monkey prefrontal cortex. Journal of Neurophysiology, 63, 1401-1412.
95. Seeman, P. (1990). Atypical neuroleptics: Role of multiple receptors, endogenous dopamine, and receptor linkage. Acta Psychiatrica Scandinavica, 82 (Suppl.), 14-20.
96. Shepherd, G.M. (1988). Neurobiology. New York: Oxford University Press.
97. 11C-raclopride in normal human subjects. Neuropsychopharmacology, 18, 18-25.
98. Smith, J.M., & Misiak, H. (1976). Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects. A review. Psychopharmacology, 47, 175-182.
99. Smith, S.L. (1968). Extraversion and sensory threshold. Psychophysiology, 5, 293-299.
100. Stelmack, R.M. (1981). The psychophysiology of extraversion and neuroticism. In H.J. Eysenck (Ed.), A model for personality (pp. 38-64). Berlin: Springer.
101. Stelmack, R.M. (1985). Personality and motor activity: A psychophysiological perspective. In B. Kirkcaldy (Ed.), Individual differences in movement (pp. 192-213). Lancaster, UK: Medical & Technical Publications.
102. Stelmack, R.M. (1990). The biological basis of extraversion: Psychophysiological evidence. Journal of Personality, 58, 293-311.
103. Stelmack, R.M., Achorn, E., & Michaud, A. (1977). Extraversion and individual differences in auditory evoked response. Psychophysiology, 14, 368-374.
104. Stelmack, R.M., Houlihan, M., & McGarry-Roberts, P.A. (1993). Personality, reaction time, and event-related potentials. Journal of Personality and Social Psychology, 65, 399-409.
105. Stenberg, G., Rosen, I., & Risberg, J. (1990). Attention and personality in augmenting/reducing of visual evoked potentials. Personality and Individual Differences, 12, 1243-1254.
106. Stricker, E.M., & Zigmond, M.J. (1986). Brain monoamines, homeostasis, and adaptive behavior. In American Physiological Society (Ed.), Handbook of physiology. Section 1. The nervous system. Vol. IV. Intrinsic regulatory systems of the brain (pp. 677-700). Bethesda, MD: American Physiological Society.
107. Svensson, A., & Carlsson, M.L. (1992). Injection of the competitive NMDA receptor antagonist Ap-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation. Neuropharmacology, 31, 513-518.
108. Verma, A., & Moghaddam, B. (1996). NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine. Journal of Neuroscience, 16, 373-379.
109. 11C]raclopride PET study of a model psychosis in humans. Journal of Psychiatric Research, 34, 35-43.
110. Walker, R.J. (1986). Biosynthesis, storage and release of dopamine. In W. Winlow & R. Markstein (Eds.), The neurobiology of dopamine systems (pp. 3-24). Manchester, UK: Manchester University Press.
111. Waters, N., Lundgren, C., Hansson, L.O., & Carlsson, M.L. (1996). Concurrent locomotor stimulation and decrease in dopamine in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755. Journal of Neural Transmission, 103, 117-129.
112. Wedzony, K., Klimek, V., & Golembiowska, K. (1993). MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Research, 622, 325-329.
113. Wesemann, W., Sontag, K.H., & Maj, J. (1983). Zur Pharmakodynamik und Pharmakokinetik des Memantin [Pharmacodynamics and pharmacokinetics of memantine]. Arzneimittel-Forschung, 33, 1122-1134.
114. Westlind-Danielsson, A., Gustafsson, K., & Andersson, I. (1994). Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro. European Journal of Pharmacology, 288, 89-95.
115. Williams, G.V., & Goldman-Rakic, P.S. ((1995). Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature, 376, 549-550.